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 Missed Parkinson’s disease (PD) medications when patients 
are admitted to hospital are associated with increased 
 morbidity and mortality. Swallowing diffi culties in hospital-
ised PD patients are common and should prompt clinicians to 
 consider conversion of a patient’s PD medications to a non-oral 
form – this is, however, recognised as a challenging area with 
potential for error. Northumbria Healthcare NHS Foundation 
Trust’s PD service set out to address this patient safety issue 
through the development of an innovative online medication 
 calculator ( pdmedcalc.co.uk ). This article summarises the devel-
opment process underpinning the calculator, presents numeri-
cal data on the usage of the calculator and presents survey 
data  relating to user experiences of the calculator. Lastly, we 
highlight how user feedback has been used to refi ne subse-
quent iterations of the calculator and how use of the calculator 
has rapidly spread beyond our trust because of it being freely 
accessible online. 
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 Introduction 
 Parkinson’s disease (PD) is the second most common 
neurodegenerative condition with increasing prevalence. 1 
It is recognised that control of PD often deteriorates in 
hospital because of incorrect medication administration. 2 As 
highlighted by a National Patient Safety Agency alert, sudden 
cessation of PD medications can be extremely dangerous. 3 
Missing dopaminergic medications can precipitate neuroleptic 
malignant-like syndrome, which is potentially fatal. 4 
 When PD patients are admitted to hospital, they may be 
made ‘nil by mouth’ (NBM) because of concerns about 
swallowing safety or in advance of a procedure. In such 
situations, appropriate conversion of PD medication to a 
non-oral form is essential. 5 Within ‘daylight’ working hours, 
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expert advice can usually be sought from local PD specialists. 
Outside these hours, however, there is potential for harm. It is 
recognised that junior doctors lack a detailed understanding 
about safe prescribing practice for PD medications 6 and that 
conversion of PD drugs to non-oral forms is a particularly 
challenging area. 7 
 The Northumbria Healthcare NHS Foundation Trust 
(NHCT) PD service (which covers a population of 
approximately 500,000 people across 10 inpatient sites) sought 
to develop a safer system to address this challenging area. In 
this article, we describe the development of an innovative, 
online PD medication calculator to assist with conversion of a 
patient’s PD medication to a non-oral form. 
 Methodology 
 Funding for the development of our online PD medication 
calculator came from the NHCT PD service, who worked 
in collaboration with a computer scientist from Newcastle 
University to develop it. 
 Initially, it was proposed that we would develop an application 
for use on internet-enabled smartphones. Subsequent 
discussion highlighted a number of difficulties with this 
approach. Firstly, mobile phone reception is often suboptimal 
within hospital buildings, which may adversely affect usability. 
Secondly, regular updates would be needed to keep pace with 
updates of smartphone operating system software, which would 
prove costly and time consuming. As such, it was agreed that 
the calculator would instead be based on the trust intranet, as 
well as the internet ( http://pdmedcalc.co.uk/ ). 
 The calculator itself was designed to be simple and intuitive. 
Computer science expertise was sought to enable the 
development of a bespoke calculator, informed by the needs of 
practising PD clinicians. Page one contained a brief explanation 
of the purpose of the calculator and prompted the user to click 
a disclaimer to proceed. Page two asked the user to select their 
patient’s current PD medication using a drop-down menu. 
Page three provided the results, in a format that could be easily 
transcribed direct onto a medication chart (Fig  1 ). 
 Two different results were provided: 
 1  a direct conversion of medication to dispersible co-beneldopa 
for administration via a nasogastric (NG) tube 
 2  a conversion to a rotigotine patch (transdermal dopamine 
agonist) for situations where an NG tube was not tolerated or 
not appropriate (eg end-of-life care). 
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 The underlying algorithms developed to calculate the doses 
were informed by previously published work. 5,8 It is recognised 
that high doses of rotigotine can, in drug-naïve patients, 
precipitate confusion, hallucinations and delirium. As such, 
a pragmatic decision was taken to reduce calculated doses of 
rotigotine by a factor of four – this was informed by the clinical 
experience of the clinicians within the PD service. This step 
was clearly signposted within the calculator, along with the 
reasoning for it, as well as the recommendation to ‘start low and 
go slow’ with up-titration of rotigotine. 
 To evaluate the use of the calculator, two approaches were 
employed. Firstly, a simple ‘hit-counter’ was incorporated into 
the results page of the tool to enable the number of users to 
be quantified. Secondly, an online survey (SurveyMonkey), 
containing a mix of multiple choice and free-text response 
questions, was developed. A link to complete this survey was 
included on the results page of the online calculator. 
 Outcome 
 The calculator was launched on the 1 July 2015. As of 1 May 
2016, the calculator had recorded a total of 1,713 users and 
20 users had provided feedback via the SurveyMonkey link. 
 Based on the 20 surveys, the calculator was predominantly 
used by medical staff (five consultants, five registrars, one core 
trainee, one foundation doctor) and by pharmacists (n=7), with 
one job title left blank. The calculator was primarily used for 
patients on medical wards (n=9), with only one user reporting 
its use on a surgical ward. The calculator was predominantly 
used within Monday to Friday ‘office hours’ (n=13) rather than 
out of hours (Mon–Fri 17:00–21:00=2, Saturday/Sunday=2). 
 Users were also asked to indicate, using a five-point Likert 
scale, how easy (or difficult) it was to: 
 a)  enter medications into the calculator 
 b)  interpret the results of the calculator. 
 Responses to these items are displayed in Fig  2 . 
 Survey respondents were also invited to provide free-
text comments on how the calculator might be improved. 
These comments are summarised in Table  1 , along with the 
subsequent changes to the calculator that were implemented 
in response to them. Of note, one survey respondent indicated 
that they had found interpretation of the calculator’s results 
to be difficult. Examining this respondent’s free-text feedback 
highlighted that they had been unclear how to proceed 
because their patient was on PD medications that did not 
appear in the drop-down menu. These particular medications 
and others (such as entacapone, selegiline, rasagiline and 
amantadine) can in fact be safely omitted when a patient is 
NBM. As described in Table  1 , additional explanatory text was 
added to the opening page of the calculator to ensure this was 
made clear. 
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 Fig 2.  How easy (or diffi cult) was the calculator to enter medications 
(A) and interpret the results (B)? 
 Table 1.  Suggestions for development emerging 
from survey data and the resulting changes that 
were implemented in response 
Suggestion for 
development 
Change implemented 
 I selected a drug 
then clicked calculate, 
but it gave an error 
that I hadn't ‘added’ 
anything. A short line 
explaining that you 
need to do this would 
be helpful. 
The following text was added:
  No medications have been added – 
please return to the previous screen and 
ensure you have correctly added the 
patient's medications 
 Minimal guidance to 
do with the other PD 
meds. 
The following text was added:
 The following medications can be safely 
omitted if swallow is compromised: 
entacapone, selegiline, rasagiline and 
amantadine. 
 Need to understand 
how it has been 
validated; referencing 
doesn't appear to be 
comprehensive 
References were included in initial 
version. 5,8 For improved access, links were 
added to enable users to access these 
references direct from the calculator.
 Not sure about 
levodopa to 
rotigotine conversion. 
Seems to give 
very low doses of 
rotigotine 
Specific guidance on this did already 
exist within the calculator. To render it 
more visible, the sub-heading “ Caution 
with Rotigotine Patch ” was inverted in 
colour and was placed directly below the 
rotigotine dose output.
 Fig 1.  An example of the online Parkinson's disease medication 
calculator’s results page. 
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 Conclusion and next steps 
 Thus far, the medication calculator has proven to be a 
success, as evidenced by the large number of users since its 
launch. Initially, the growth in users was slow. We suspect 
these initial users were predominantly within our trust and 
were directed to the calculator via the NHCT trust guideline 
for PD, which advocates use of the calculator for NBM PD 
patients. Thereafter, the growth in users has steadily increased. 
This has been driven by the calculator being endorsed by 
the British Geriatrics Society Movement Disorders Section 
and more recently, through recognition of the calculator by 
the Parkinson’s UK Excellence Network. Subsequently, the 
Parkinson’s UK Excellence Network have incorporated the 
calculator into their regional NBM guideline, which is currently 
in use across the north-east of England and Cumbria. 9 
 We acknowledge that the number of survey respondents, 
compared with the number of users, is small and hence caution 
must be employed when analysing the survey results. We 
suspect that response to the survey has been low because users 
will typically access the calculator in the clinical workplace and 
pressures of work may mean that they are less inclined to access 
and complete an online survey. The primary motivation for the 
survey, however, was to source feedback as to how the calculator 
could be improved, and not to provide a comprehensive 
overview of who was using the calculator and the environments 
in which they were doing so. 
 We aim to increase awareness of the calculator within our 
trust through an advertising campaign, coordinated via the 
trust’s communications team. An advert for the calculator 
will be incorporated into the rolling screensaver that appears 
on all trust computers. We anticipate this will give excellent 
exposure to the calculator and drive further use within the 
clinical workplace. Orientation to the tool has already been 
incorporated into trust-wide junior doctor teaching on PD – 
further feedback from these users (who were comparatively 
under-represented in our survey) may inform improvements 
in future iterations of the tool. Future work could also consider 
capturing data pertaining to clinically meaningful outcome 
measures, such as the incidence of medication errors with PD 
medications, before and after the implementation of the tool. 
Lastly, we hope that sharing our innovation via  Future Hospital 
Journal will help raise awareness of the calculator among 
physicians around the world. 
 Key learning points 
 >  Being ‘nil by mouth’ and missing PD medications is a 
potential patient safety issue. 
 >  In such patients, working out a suitable non-oral medication 
regimen can be challenging for junior doctors, particularly 
out of hours. 
 >  Computer science expertise was central to the development 
of an intuitive, reliable medication calculator. 
>  Making the medication calculator freely accessible on the 
internet ( pdmedcalc.co.uk ) has enabled its use to spread 
beyond our trust. 
>  Endorsement and dissemination of the calculator by 
professional bodies has further enhanced its use across the UK. 
 >  Capturing user feedback, and modifying the calculator in 
light of it, was a crucial part of maximising usability of the 
calculator. ■ 
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